Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 27;5(1):35.
doi: 10.1186/s42466-023-00260-w.

SOP: acute hyperkinetic movement disorders

Anna Sauerbier  1 , Alexandra Gronostay  1 , Haidar S Dafsari  2   3
Affiliations

SOP: acute hyperkinetic movement disorders

Anna Sauerbier et al. Neurol Res Pract. .

Abstract

Introduction: Movement disorders emergencies describe acute-onset neurological conditions in which a delay of recognition and treatment may cause severe morbidity and mortality of patients. Hyperkinetic movement disorders include tremor, chorea/ballism, dystonia, myoclonus, and tics. Here we present a standard operating procedure (SOP) for the diagnostic work-up and different treatment options depending on the phenomenology as well as the aetiology of underlying diseases.

Comments: The recognition of the phenomenology is essential for the symptomatic therapy of the acute movement disorder and forms the basis for the choice of ancillary investigations to confirm the suspected underlying causes. Furthermore, we summarise diagnostic techniques, including blood and cerebrospinal fluid tests and neuroimaging, which provide rapid results and are useful for the indication of causal treatments of specific acute movement disorders.

Conclusions: Despite their acute nature, most of these conditions can result in good clinical outcomes, if recognised early.

PubMed Disclaimer

Conflict of interest statement

Anna Sauerbier is funded by the Gusyk program and the Advanced Cologne Clinician Scientist program of the Medical Faculty of the University of Cologne and has received funding from the Prof. Klaus Thiemann Foundation. Alexandra Gronostay reports no disclosures. Haidar S. Dafsari reports funding of his work by the EU Joint Programme – Neurodegenerative Disease Research (JPND), the Prof. Klaus Thiemann Foundation, the Felgenhauer Foundation, and the Koeln Fortune Program, and honoraria by Boston Scientific, Medtronic, Oruen, Everpharma, and Stadapharm.

Figures

Fig. 1
Fig. 1
Flow chart SOP acute hyperkinetic movement disorders
See this image and copyright information in PMC

References

    1. Jankovic J. Treatment of hyperkinetic movement disorders. Lancet Neurology. 2009;8(9):844–856. doi: 10.1016/S1474-4422(09)70183-8. - DOI - PubMed
    1. Jankovic, J., & Lang, A. E. (2004). Movement disorders: diagnosis and assessment. Neurology in Clinical Practice, 293–322.
    1. Gandhi SE, Newman EJ, Marshall VL. Emergency presentations of movement disorders. Practical Neurology. 2020;20(4):practneurol–2019. doi: 10.1136/practneurol-2019-002277. - DOI - PubMed
    1. Frucht SJ, Termsarasab P. Movement Disorder Emergencies. In: Frucht SJ, Termsarasab P, editors. Movement disorders phenomenology: An office-based approach. Cham: Springer International Publishing; 2020. pp. 239–249.
    1. Jost, W. H., & Müller, J. (2020). Drugs in the treatment of dystonia, multisystem atrophy, and non-parkinson tremor. NeuroPsychopharmacotherapy, 1–16.

LinkOut - more resources